Protara Therapeutics, Inc. (TARA) Social Stream



Protara Therapeutics, Inc. (TARA): $3.22

0.29 (+9.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TARA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 437

in industry

Protara Therapeutics Inc (TARA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Protara Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 3 $50 $34 $40.5 $5.02 706.77%
2022-03-10 4 $50 $34 $40.5 $5.02 706.77%
2022-03-14 4 $50 $32 $40 $5.02 696.81%

The Trend in the Analyst Price Target


Over the past 51 weeks, TARA's average price target has gone down $5.25.

TARA reports an average of 406.08% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 3 50 32 41.5 10.19 307.26%
2021-07-17 4 50 32 41.2 8.27 398.19%
2021-07-24 4 50 32 41.2 8.38 391.65%
2021-08-28 4 50 32 41.2 8.13 406.77%
2022-03-14 4 50 32 40.0 4.25 841.18%

TARA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 39 weeks, TARA's average broker recommendation rating improved by 0.25.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TARA as an investment opportunity.

  • In the context of all US stocks, Protara Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 293.39% of them.
  • In terms of how Protara Therapeutics Inc fares relative to stocks in the micro market cap category, note that its average analyst price target is greater than 287.65% of that group.
  • TARA has a higher number of analysts covering the stock than 58.56% of Pharmaceutical Products stocks.
  • In terms of how Protara Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -2.76% of that group.

In the Pharmaceutical Products industry, RCOR, PSTI, and PMCB are the three stocks most similar to Protara Therapeutics Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for TARA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5965 seconds.